Related Experiment Video

Updated: Dec 25, 2025

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

9.2K

25 Years of Kaposi Sarcoma Herpesvirus: Discoveries, Disparities, and Diagnostics

Devon E McMahon1, Toby Maurer2, Esther E Freeman1

  • 1Massachusetts General Hospital, Harvard Medical School, Boston, MA.

JCO Global Oncology
|March 29, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.0K
Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

718

Related Experiment Videos

Last Updated: Dec 25, 2025

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

9.2K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.0K
Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

718

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K

Articles linked to this work by shared authors, journal, and citation graph.

Dermatological Manifestations of Emergent Viruses. Part II: Vector-Borne and Opportunistic Viral Infections.

Journal of the American Academy of Dermatology·2026

Dermatological Manifestations of Emergent Viruses. Part I: Common and Vaccine-Preventable Viral Infections.

Journal of the American Academy of Dermatology·2026

What Will it Take to Scale-Up Teledermatology? Providers' Perspectives in Kenya and Uganda.

Clinical and experimental dermatology·2026

Global Disparities in Access to Dermatological Care.

JAMA dermatology·2026

The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Implementation of teledermatology to identify and expedite care for Kaposi sarcoma.

AIDS (London, England)·2026

Ethnic and Geographic Variation in Prostate Cancer Presentation in Suriname.

JCO global oncology·2026

Generative Artificial Intelligence Use, Perceptions, and Expectations Among Argentine Oncology Health Care Professionals: A Cross-Sectional Survey.

JCO global oncology·2026

Barriers and Facilitators Influencing National Scaleup of a Women's Cancer Early Detection Program in Rwanda: Perspectives of Policymakers, Program Leaders, and Clinicians.

JCO global oncology·2026

Gap Between Estimated Need and Observed Uptake of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Among Patients With Lung Cancer in Indonesia.

JCO global oncology·2026

Sociodemographic and Clinicopathologic Characteristics of Patients With Invasive Breast Cancer in Latin America: The LATINA Breast Cohort (LACOG 0615/MO39485).

JCO global oncology·2026

Global Study of Perceptions of Patient Navigation for Older Adults With Cancer.

JCO global oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us